chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Bone pain, Diarrhoea, Myalgia, Pyrexia, Vomiting
Clinical narrative: This authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 63 year old female patient. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 15-Oct-2015- unknown stop date, Batch no: U59508, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Unknown. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 16-Oct-2015, 2 days after starting / treatment with AFLURIA the patient experienced Bone pain (non serious, outcome: Recovered / Resolved), Uncontrolled diarrhea (non serious, outcome: Recovered / Resolved), Fever (non serious, outcome: Recovered/ Resolved), Muscle pain (non serious, outcome: Recovered/ Resolved). On 22-Oct-2015, 1 week 1 day after starting / treatment with AFLURIA the patient experienced vomiting (non serious, outcome: Recovered / Resolved). Feeling better 23-Oct-2015.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Crying, Depression, Feeling abnormal, Mobility decreased
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 69 year old female patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 12-Oct-2015- unknown stop date, Batch no: not provided, Route of administration: not provided, Dose: no information provided. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 13-Oct-2015, 2 days after starting/ treatment with AFLURIA the patient experienced Depressed (non serious, outcome: Recovered/Resolved), Crying (non serious, outcome: Recovered/ Resolved), Unable to get out of bed (emotionally)/ Reluctant to even speak (non serious, outcome: Recovered/Resolved), Felt like a freight train had hit me (non serious, outcome: Recovered/ Resolved.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 47 year old female patient. Concurrent medical condition (s), medical and drug history: The patient has a medical history of Latex allergy, Penicillin allergy, Diabetic, Received infused blood products in the past and MEFOXIN allergy. The patient had no illness at the time of vaccination. The following drug history information was reported: Penicillin (Indication-, Reaction: Allergy) and MEFOXIN (Indication: -, Reaction: Allergy). Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 20-Ocr-2015- unknown stop date, Batch no: U59208 reported as 'U59280', Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 20-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Acute allergic reaction (non serious, outcome: Recovered/Resolved, Fever (non serious, outcome: Recovered/Resolved).
Age: 40.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site exfoliation, Injection site haemorrhage, Injection site pain, Injection site scab
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 40 year old male patient. The patient had no medical history, concomitant medication and allergies at the time of vaccination. Suspect drug (s), timing and conditions surround the onset of reaction (s)/ event (s): The patient received AFLURIA for indication not reported on 03-Oct-2015- unknown stop date, Batch no: U56506, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). Lab data: None. Additional suspect drug (s): No additional drug suspected. Reaction (s)/ event (s) and outcome: On 03-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced when the vaccine was administer it bleed (non serious, outcome: Recovered/Resolved). On 06-Oct-2015, 4 days after starting/ treatment with AFLURIA the patient experienced Skin peel back in the area where I got the shot (non serious, outcome: Recovered/ Resolved), [It was painful] in the area [then] a scab had formed over it (non serious, outcome: Recovered/ Resolved), in the area where I got the shot a small sore had formed (non serious, outcome: Recovered/ Resolved), it was painful in the area [then a scab had formed over it] (non serious, outcome: Recovered/ Resolved).
Age: 66.0
Sex: F
Vaccine: FLU3, PNC13, VARZOS
Symptoms: Injection site swelling, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns  66 year old female patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 08-Oct-2015 - unknown stop date, Batch no: U56606, Route of administration: intramuscular, Dose: 0.5 ml, site: left arm (LA). PREVNAR 13, Indication: not provided. Site: Left arm (LA) and ZOSTAVAX, indication: not provided, site: Right arm (RA). On 09-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced swelling of upper and lower right arm. Ultrasound of right arm. Reporter's assessment: Non-serious.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Fall
Clinical narrative: This case report was received from a Health Professional and concerns a 33 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received AFLURIA on 26-Oct-2015, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 26-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced felt dizzy for more than 10 minutes, Fall on the floor after flu vaccine administration. Action taken: Called 911. Reporter's assessment: Non-Serious.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site urticaria
Clinical narrative: The case report was received from a Health Professional and concerns a 57 year old female patient. Concurrent medical condition (s), medical and drug history: The patient had a medical history of High blood pressure. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surround the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 13-Oct-2015- unknown stop date, Batch no: U54506, Route of administration: Unknown, Dose: 0.5 ml, Site: Left arm (LA). Additional suspect drug (s): ZOSTAVAX, Indication: not provided, Site: Left arm (LA). Both vaccines were given in the left arm (medication error not explicitly reported). Reaction (s)/ event (s) and outcome: On 15-Oct-2013, 3 days after starting/ treatment with AFLURIA the patient experienced hives at injection site (non serious, outcome: Unknown). VAERS ID: 605037.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site induration, Injection site pain, Injection site paraesthesia, Injection site warmth
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 24 year old female patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015, Batch no: 11949211A, Route of administration: not provided, Site: Right arm (RA). No additional drugs suspected. On an unknown date, after starting treatment with AFLURIA the patient experienced Heat, tingling (in (R) shoulder), [Pain and] induration at site of injection ((R) deltoid M). Reporter's assessment: Non-serious.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Costochondritis, Dyspnoea, Nausea, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 25 year old female patient. The patient has a medical history of Endometriosis. Donor stated previous hx of CPR in the past-unsure what caused her heart to stop at that time. The patient was just getting over a viral resp infection at the time of vaccination. The patient received AFLURIA on 21-Oct-2015, Batch no: not provided, Route of administration: not provided, Dose: no information provided. No additional drugs suspected. On 23-Oct-2015, 3 days after starting treatment with AFLURIA the patient experienced Chest pain, SOB, left arm pain, pale, Costochondritis, and nausea. After discussion with center medical director donor was sent via ambulance to Medical center for evaluation; donor was discharged same day with diagnosis of Costochondritis; patient states she was told by ER doctor that the Costochondritis was probably due to recent flu vaccine. Reporter's assessment: Non-serious.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Pallor
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 25 year old female patient. The patient has a medical history of Endometriosis. Donor stated previous hx of CPR in the past-unsure what caused her heart to stop at that time. The patient was just getting over a viral resp infection at the time of vaccination. The patient received AFLURIA on 21-Oct-2015, Batch no: not provided, Route of administration: not provided, Dose: no information provided. No additional drugs suspected. On 23-Oct-2015, 3 days after starting treatment with AFLURIA the patient experienced Chest pain, SOB, left arm pain, pale, Costochondritis, and nausea. After discussion with center medical director donor was sent via ambulance to Medical center for evaluation; donor was discharged same day with diagnosis of Costochondritis; patient states she was told by ER doctor that the Costochondritis was probably due to recent flu vaccine. Reporter's assessment: Non-serious.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Dyspnoea
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 77 year old male patient. The patient has a medical history of Hypertension and anticoagulated. Conomitant medications include 'nothing new'. The patient had no illness at the time of vaccination. The patient received a 7th dose of AFLURIA on 17-Oct-2015 - unknown stop date, Batch no: 11649211A, Route of administration: Intramuscular, Site: Unknown. No additional drugs suspected. On 17-Oct-2015, 1 hour after starting / treatment with AFLURIA the patient experienced Difficulty breathing, Chills. No fever, no problems at injection site. Symptoms persisted through the night but were improving the next day (approx. 24 hrs later) patient took some diphenhydramine. VAERS ID: 605113. Reporter's assessment: Non-serious.
Age: 52.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Local reaction, Pain in extremity, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a with unknown age and gender. Weight: not provided, Height: not provided. The patient has a medical history of COLAZAL; Sulfa (allergy). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 18-Oct-2015 - unknown stop date, Batch no: U51009, Route of administration: Unknown, Dose: 0.5 ml. ZOSTAVAX, Indication: not provided. On 20-Oct-2015, 3 days after starting / treatment with ALFURIA the patient experienced Left arm swelling, Left arm pain, Local reaction, fairly large. For relevant test results see appropriate report section. Reporter's assessment: The health authority assessed the events as non-serious. VAERS ID: 605180. Case corrections (11-Mar-2016): Listedness for AE 3 changed to listed.
Age: 62.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Cheilitis, Oral mucosal erythema, Stomatitis, Tenderness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 62 years old male patient. At the time of the event the patient concomitantly suffered from Urinary tract infection. The patient received AFLURIA on 20-Oct-2015, Batch no: U56907, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug(s): PNEUMOVAX (batch no: L003227). On 23-Oct-2015, 4 days after starting treatment with AFLURIA the patient experienced sores inside of mouth, sores and redness on lips and around lips, redness inside of mouth, and tender to the touch. Reporter's assessment: Non serious.
Sex: U
Vaccine: FLU3
Symptoms: Pain, Paraesthesia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a patient with unknown age and gender. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on unknown dates, Batch no: U59408, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On an unknown date, after starting / treatment with AFLURIA the patient experienced Throbbing, Tingling. For relevant test results see appropriate report section. Reporter's assessment: The health authority assessed the events as non-serious. VAERS ID: 605408.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dizziness, Nausea, Palpitations, Throat tightness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 58 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Breast cancer. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Oct-2015 around 4pm - unknown stop date, Batch no: U54205, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 14-Oct-2015, between 6-6:30pm the patient experienced Throat was closing up, Chills, Nausea, Heart was racing, Light-headed. The patient took diphenhydramine and a half hour later, felt better. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 605947.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Swelling face
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 60 year old female patient. The patient has a medical history of seafood allergy, hypertension (HTN) and diabetes mellitus type 2 (DM II). The patient received AFLURIA on 22-Oct-2015, Batch no: 11749221A, Route of administration: Intramuscular, Site: Left arm (LA). No additional drugs suspected. On 22-Oct-2015, 1 hour after starting treatment with AFLURIA the patient experienced facial itching (non serious, outcome: Recovered/Resolved), PO diphenhydramine 25 mg. On 22-Oct-2015, 2 hours after starting treatment with AFLURIA the patient experienced left sided facial swelling - no airway obstruction (non serious, outcome: Recovered/Resolved). Diphenhydramine 50 mg IM with no relief. Taken to ER via ambulance discharged same day.  Event treatment: Diphenhydramine. Lab data: CBS, CMP at ER. Reporter's assessment: Non-serious.
Age: 80.0
Sex: M
Vaccine: FLU3
Symptoms: Blood glucose increased
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 80 years old male patient. Weight: not provided, Height: not provided. The patient has a medical history of Diabetes. The patient had no current illness. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 28-Oct-2015 - unknown stop date, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 29-Oct-2015, 2 days after starting / treatment with AFLURIA the patient experienced Increased blood glucose. His blood glucose usually ran around 95, readings day after vaccine were 172 and 184. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID:  606282.
Age: 57.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Dizziness, Hypersensitivity, Injection site rash, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 57 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Mouth cancer (not on chemo). She had no acute illnesses. For concomitant medication and therapy dates refers to the appropriate report sections. The patient received AFLURIA on 27-Oct-2014 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, site left arm. On the same day, the patient received PNEUMOVAX (batch no: K010523) in the right arm, Indication: not provided. On 28-Oct-2015, after starting treatment with AFLURIA the patient experienced Dizziness, Allergic reaction, Rash at and around injection site, Rash extending down arm almost to elbow, Fever, Chills. Symptoms resolved on 30-Oct-2015. Patient took acetaminophen to control fever and chills. For relevant test results see appropriate report section. Reporter's assessment: Non serious. VAERS ID: 606300. Follow-up received 26-Feb-2016. On 27-Oct-2015, the patient was vaccinated with AFLURIA and PNEUMOVAX. Case evaluation and comment: No change to assessment.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a (n) 55 years old. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no current illness and no known allergies. The patient received AFLURIA on 22-Oct-2015 - unknown stop date, Batch no: U58808, route of administration: intramuscular, dose: 0.5 ml, site: left arm. On the same day the patient also received PNEUMOVAX (batch no: L022262) in the left arm, indication: not provided. On 23-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced arm was swollen, sore arm, arm was red. The patient decided to go to the emergency room 2 days after the injection. For relevant test results see appropriate report section. Reporter's assessment: non serious
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Local swelling, Pruritus
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 27 years old female patient. The patient had no current illness nor medical history. The patient received AFLURIA on 28-Oct-2015, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 29-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced red area roughly 2-2.5 inches below the injection site, slightly swollen area roughly 2-2.5 inches below the injection site, and itchy area roughly 2-2.5 inches below the injection site. The area was roughly 2 inches in diameter. Reporter's assessment: Non serious.
Age: 60.0
Sex: U
Vaccine: FLU3, PPV
Symptoms: Injection site reaction, Rash erythematous
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 60 years old patient with unknown gender. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no current illness nor medical history. The patient received AFLURIA on 21-Oct-2015 - unknown stop date, Batch no: 'U54807' (not valid CSL batch number), Route of administration: Intramuscular, Dose: Site left arm. On the same day the patient also received PNEUMOVAX (batch no: L022795) in the left arm, Indication: not provided. Both vaccines were administered in the left arm (medication error not explicitly reported). On 22-Oct-2015, 2 days after starting / treatment with AFLURIA the patient experienced Red rash from shoulder, running down to elbow of left arm, Injection site reaction. For relevant test results see appropriate report section. Reporter's assessment: Non serious. . VAERS ID: 606428.
Age: 62.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Asthenia, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 62 year old female patient. The patient received AFLURIA on 25-Sep-2015 - unknown stop date, Batch no: U58608, Route of administration: Intramuscular, Dose, 0.5 ml, site: Left arm (LA). ZOSTAVAX (batch no: K023008), indication: not provided, route: subcutaneous, site: left arm (LA). AFLURIA and ZOSTAVAX both administered to left arm. On an unknown date, after starting/treatment with AFLURIA the patient experienced extreme weakness, swelling of upper arm, swelling of upper arm with extreme pain, nausea. Reporter's assessment: Non serious.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Pruritus, Rash, Vomiting
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 32 year old female patient. The patient has a medical history of Multiple allergies and Lupus. The patient had no illness at the time of vaccination. The patient received AFLURIA on 30-OCT-2015, Batch no: U57507, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 30-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced vomiting, rash over trunk and then arms, legs. On 30-Oct-2015, 12 hours after starting treatment with AFLURIA the patient experienced tingling in hands and feet. On 30-Oct-2015, 3 hours after starting treatment with AFLURIA the patient experienced Pruritus. Reporter's assessment: Non serious.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Joint range of motion decreased, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec 2015. The case report was received from a Health Professional and concerns a 24 year old female patient. The patient has no medical history and had no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 15-Oct-2015, 2 days after starting treatment with AFLURIA the patient experienced Intense sharp pain in her left arm that lasted throughout the day, Limited range of motion, Pt felt the vaccine was given too high. Since then the pain has decreased. She has been taking ibuprofen to help the pain. Lab data: Unknown. Reporter's assessment: Non serious. VAERS ID: 606456.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site inflammation, Injection site pain, Joint range of motion decreased, X-ray
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 58 year old female patient. The patient has a medical history of PCN allergy and Sulfa allergy. The following drug history information was reported: PCN (Indication: -, Reaction: Allergy) and Sulfa (Indication: -, Reaction: Allergy). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA  (dose number: 1) on 15-Oct-2015 - unknown stop date, Batch no: U58207, Route of administration: Unknown, Dose: 0.5 ml, Site: Left deltoid. No additional drugs suspected. On 15-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced No range of motion, "Severe inflammation" at injection site (left deltoid), "Severe pain" at injection site (left deltoid). Patient went to urgent care referred to orthopedics, received x-rays. Reporter's assessment: Non serious. VAERS ID: 606473.
Age: 38.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Nasal congestion, Ocular hyperaemia, Pruritus, Vision blurred
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 38 year old male patient. The patient has a medical history of Diabetic and PCN allergy. The patient had no illness at the time of vaccination. The following drug history information was reported: Penicillin (Reaction: Allergy). The patient received AFLURIA on 30-Oct-2015, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 30-Oct-2015, between 7:30 pm and 9 pm the patient experienced coughing sensation, nasal congestion, blurred vision, bloodshot eyes, and itching. He was recovered by morning. Lab data: None. Reporter's assessment: Non serious.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Decreased appetite, Headache, Impaired work ability, Nausea, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 31 year old female patient. The patient has a medical history of Allergy to codeine - anaphylaxis. The patient had no illness at the time of vaccination. The following drug history information was reported: Codeine (Indication: -, Reaction: Anaphylaxis). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 26-Oct-2015 - unknown stop date, Batch no: U57507, Route of administration: Intramuscular, Dose: 0.5 ml, Site: LA (LA). No additional drugs suspected. On 26-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Vertigo, Body aches and pains, Loss of appetite, Severe enough to call in sick to work for two days, Headache, Fever 101 F, Nausea. Acetaminophen 500 mg x 2 doses (not effective); diphenhydramine 50 mg x 1 dose (not effective). Reporter's assessment: Non serious. VAERS ID: 606533.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Vertigo
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 31 year old female patient. The patient has a medical history of Allergy to codeine - anaphylaxis. The patient had no illness at the time of vaccination. The following drug history information was reported: Codeine (Indication: -, Reaction: Anaphylaxis). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 26-Oct-2015 - unknown stop date, Batch no: U57507, Route of administration: Intramuscular, Dose: 0.5 ml, Site: LA (LA). No additional drugs suspected. On 26-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Vertigo, Body aches and pains, Loss of appetite, Severe enough to call in sick to work for two days, Headache, Fever 101 F, Nausea. Acetaminophen 500 mg x 2 doses (not effective); diphenhydramine 50 mg x 1 dose (not effective). Reporter's assessment: Non serious. VAERS ID: 606533.
Age: 67.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Administration site swelling, Influenza like illness, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 67 year old female patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 23-Oct-2015 - unknown stop date, Batch no: U58908, Route of administration: Unknown, Dose: 0.5 ml, Site: Left arm (LA). ADACEL (batch number: U5278AA, route: unknown), Indication: not provided, site: right (RA). On 24-Oct-2015, 2 days after starting treatment with AFLURIA that patient experienced Flu-like symptoms, raised area near administration site/raised area 3 inches, administration site; soreness. itching in context of injection site, red in context of injection site. Reporter's assessment: non serious.
Age: 67.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injection site swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 67 year old female patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 23-Oct-2015 - unknown stop date, Batch no: U58908, Route of administration: Unknown, Dose: 0.5 ml, Site: Left arm (LA). ADACEL (batch number: U5278AA, route: unknown), Indication: not provided, site: right (RA). On 24-Oct-2015, 2 days after starting treatment with AFLURIA that patient experienced Flu-like symptoms, raised area near administration site/raised area 3 inches, administration site; soreness. itching in context of injection site, red in context of injection site. Reporter's assessment: non serious.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 53 year old male patient. The patient has no relevant medical history and had no illness at the time of vaccination. The patient received AFLURIA (dose number: 18) on 04-Oct-2015 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On an unknown date, after starting treatment with AFLURIA the patient experienced (L) shoulder pain / significant pain when palpated, Couldn't lift his arm in line w/ his shoulder, Mobility decreased. Lab data: MRI. Reporter's assessment: Non serious. The health authority reported the symptom: mobility decreased. VAERS ID 606552.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Skin tightness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 35 year old female patient. The patient had a medical history of endometriosis. Concomitant medications include 'birth control'. The patient had no illness at the time of vaccination. The patient received AFLURIA on 15-Oct-2015 - unknown stop date, Batch no: U58107, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm. No additional drugs suspected. On 17-Oct-2015, 3 days after starting treatment with AFLURIA the patient experienced Soreness/Pain, Tightness, Skin tightness. Soreness and tightness on day 1. Pain on day 3-4. Been on steroid for 4 days, will continue for 3 more days and then reevaluated. Reporter's assessment: Non serious. The health authority reported the symptom: skin tightness. VAERS ID: 606614.
Age: 58.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Feeling cold, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 58 year old male patient. The patient has no known allergies and had no illness at the time of vaccination. Concomitant medications are unknown. The patient received AFLURIA on 10-Oct-2015 - unknown stop date, Batch no: U57907 reported as 'us7907', Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 10-Oct-2015, 5 hours after starting treatment with AFLURIA the patient experienced Fever, Chills and the rigors. The patient did not call the pharmacy or doctor. It lasted about 18 hours. The patient is not sure if it was from the shot or an allergy to something else. Reporter's assessment: Non serious. VAERS ID: 606628.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased
Clinical narrative: This health authority case initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 55 years old female patient. Weight: not provided, Height: not provided, For concomitant medication and therapy dates refer to the appropriate report sections. The patient had no medical history or current illness. The patient received AFLURIA on 17-Oct-2015 - unknown stop date, Batch no: U56406, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. No additional drugs suspected. On 01-Nov-2015, 2 weeks 4 days after starting/treatment with AFLURIA the patient experienced she can't raise her arm and mobility decreased. Reporter's assessment: The health authority assessed the events as non-serious.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 57 year old female patient. The patient had no medical history and no illness at the time of vaccination. The patient received ALFLURIA on 17-Oct-2015  - unknown stop date, Batch no: U55806, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 17-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced Pain in site of injection. It went away, but then it came back again after a couple of weeks. Reporter's assessment: Non serious. VAERS ID: 607039.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Urticaria
Clinical narrative: This health authority case was initially received on 16-Dec-2015.  The case report was received from a Health Professional and concerns a 64 old female patient. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 08-Sep-2015 - unknown stop date, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 08-Sep-2015, 3 hours after starting / treatment with AFLURIA the patient experienced Headache, Hives. The patient took some diphenhydramine. VAERS ID: 607144.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Dyspnoea, Headache, Rash, Urticaria
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 42 year old female patient. The patient received AFLURIA on 14-Oct-2015, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 14-Oct-2015, after starting treatment with AFLURIA the patient experienced short of breath, dizziness, constant headache, rash, and hives. Reporter's assessment: Non serious.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Dizziness, Headache, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a   52 year old female patient. The patient has a medical history of Fibromyalgia, Chronic kidney disease and Gout. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 14-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Lightheaded, Body aches, Chills. On 14-Oct-2015, 12 hours after starting / treatment with AFLURIA the patient experienced Headache. Reporter's assessment: Non serious. VAERS ID: 607178.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 59 year old male patient. The patient had no medical history, concomitant medications or illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 14-Oct-2015  07:00, 1 day after starting treatment with AFLURIA the patient experienced achy. On 14-Oct-2015 19:30, after starting treatment with AFLURIA the patient experienced Headache, Fever 101, Nauseous, and Vomited. Reporter's assessment: Non serious.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 30 year old female patient. The patient has a medical history of 'penicillin'. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 14-Oct-2015, 8 hours after starting / treatment with AFLURIA the patient experienced Fatigue, Headache, Fever. Reporter's assessment: Non serious. VAERS ID: 607182.
Age: 29.0
Sex: M
Vaccine: FLU3
Symptoms: Fatigue, Nausea, Rash
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional in the United States and concerns a(n) 29 year old male patient. The patient has a medical history of 'Advil'. The patient had no concomitant medications and no illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 14-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced fatigue, nausea, and torso rash. Reporter's assessment: Non serious.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Dizziness, Headache, Vomiting
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 21 year old female patient. The patient had no illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: right arm (RA). No additional drugs suspected. On 14-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Dizzy, Upset stomach, Headache, Threw up once. Reporter's assessment: Non serious. VAERS ID: 607188.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Headache, Rhinorrhoea
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 40 year old female patient. The patient had no medical history, concomitant medications or illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U55106, Route of administration: Unknown, Dose; 0.5 ml, Site: Unknown. No additional drugs suspected. On 14-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Nose running, Upset stomach, Head aches. Reporter's assessment: Non serious. VAERS ID: 607190. Case correction (11-Mar-2016): Assessment for AE 1, runny nose corrected to listed.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Migraine, Pain, Vomiting
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 44 year old female patient. The patient has a medical history of High blood pressure. The patient had no illness at the time of vaccination. The patient received AFLURIA on 14-Oct-2015, Batch no: U55106, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Left arm (LA). No additional drugs suspected. On 14-Oct-2015, 1 day after starting treatment with AFLURIA the patient experienced unable to function, body aches, headache migraine in nature, and vomiting. Reporter's assessment: Non serious.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea
Clinical narrative: The case report was received from a(n) Health Professional and concerns a(n) 57 year old female patient. The patient received AFLURIA on 14-Oct-2015 - unknown stop date, Batch no: U55106, Route of administration: Intramuscular, dose: 0.5 ml, site: Right arm (RA). No additional drugs suspected. On 14-Oct-2015, 1 day after starting treatment with AFLURIA the patient was nauseous. Reporter's assessment: Non serious.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Ear discomfort, Hypoaesthesia, Paraesthesia
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 34 year old female patient. The patient reported no medical history and no illness at the time of vaccination. Concomitant medications at the time of vaccination are unknown. The patient received AFLURIA on 03-Nov-2015 - unknown stop date, Batch no: U54405, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 03-Nov-2015, 1 day after starting / treatment with AFLURIA the patient experienced Numbness in right lower forearm / Numbness started to occur in left lower forearm, Right ear feels like its clogged, Tingling in right lower forearm / Tingling started to occur in left lower forearm. There were no s/s of respiratory distress or swelling noted on or around face or neck or at vaccination site. Patient was referred to emergency room. Reporter's assessment: Non serious. VAERS ID: 607346.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Nuclear magnetic resonance imaging normal, Peripheral swelling
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 56 years old male patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 03-Nov-2015, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 03-Nov-2015, 1 day after starting treatment with AFLURIA the patient experienced swelling in the lower part of his left arm. The patient underwent MRI (magnetic resonance imaging) to rule out a blood clot. The MRI was clear. The health authority assessed the event as non-serious.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Vertigo
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 53 year old male patient. The patient had no medical history and no illness at the time of vaccination. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 23-Oct-2015 - unknown stop date, Batch no: U50509, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 24-Oct-2015, 14-15 hrs after starting / treatment with AFLURIA the patient experienced Dizziness / Noticeably dizzy, especially when bending over and re-rising to standing position, Vertigo. This persisted for 3 full days beyond date of vaccination. By 27-Oct-2015, the dizziness/vertigo subsided fully. Have never experienced this before. Reporter's assessment: Non serious. VAERS ID: 607638.
Age: 19.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Peripheral coldness
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 19 year old female patient. The patient had no medical history at the time of vaccination. Concomitant medications includes 'BCP' (birth control pills). The patient received AFLURIA on 29-Oct-2015 - unknown stop date, Batch no: 11849211A, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Arm (AR). No additional drugs suspected. On 29-Oct-2015, after starting / treatment with AFLURIA the patient's Arm went completely cold / Arm was physically cold, Immediate post-injection reaction. When the patient said this to the NP (nurse practitioner), he touched her arm and said that her arm was physically cold. The patient received the vaccine at a pharmacy. The patient stayed there until the cold feeling left. The patient has had multiple other flu shots over the years and this is the first time this has ever happened. The patient is not allergic to any of the ingredients, or anything for that matter. Reporter's assessment: Non serious. The health authority coded additional term Immediate post-injection reaction. VAERS ID: 607763.
Age: 37.0
Sex: M
Vaccine: FLU3, HEPAB, TDAP
Symptoms: Drug administered at inappropriate site, Injection site pain, Pain in extremity
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a(n) Health Professional and concerns a(n) 37 year old male patient. The patient had no known allergies and no illness at the time of vaccination. The patient received AFLURIA on 19-Oct-2015, Batch no: U56907, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm (LA). Additional suspect drug(s): TWINRIX, Batch no: 3NK9A, Route: Intramuscular, Site: Left arm (LA), and ADACEL, Batch no: U5235AA, Route: Intramuscular, Site: Left arm (LA). AFLURIA, TWINRIX, and ADACEL were administered to the left arm. On an unknown date, after starting treatment with AFLURIA the patient experienced severe pain running down his left upper arm, severe pain from the injection site, injection was given high on his arm. The patient went to a physician to be checked out. X-ray of shoulder. Reporter's assessment: Non serious.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Contusion, Pain
Clinical narrative: This health authority case was initially received on 16-Dec-2015. The case report was received from a Health Professional and concerns a 50 year old female patient. The patient's medical history is unknown. It is not known whether the patient had an illness at the time of vaccination. The patient received AFLURIA on 03-Oct-2015 - unknown stop date, Batch no: U56506, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right arm (RA). No additional drugs suspected. On 03-Oct-2015, 1 day after starting / treatment with AFLURIA the patient experienced Pain has not gone away, Bruise was on my arm. Reporter's assessment: Non serious.  VAERS ID: 607996.